Mary Daly

Mary Daly is a Clinical Instructor in the Department of Psychiatry at the Yale School of Medicine. Her research focuses on cancer prevention strategies, genetic risk factors, and the impact of hormonal therapies in high-risk populations. She collaborates internationally on studies exploring breast and ovarian cancer epidemiology, including BRCA mutation carriers and Lynch syndrome patients. Her work emphasizes translational research to improve clinical decision-making and patient outcomes in oncology.

Research Interests: Dr. Daly investigates how genetic predisposition, lifestyle factors, and healthcare interventions influence cancer risk and prevention. Key areas include: (1) evaluating risk tolerance for ovarian cancer prevention strategies during pandemics, (2) assessing the efficacy of couple-based interventions for breast cancer survivors' sexual health, and (3) analyzing hormonal therapies' role in cancer risk across different familial risk groups.

Publications: Her recent work explores topics such as the association of hormonal contraception with BRCA-related breast cancer, geographic disparities in prostate cancer outcomes, and genetic determinants of puberty timing. These studies highlight her commitment to advancing evidence-based approaches in cancer prevention and personalized medicine.

Awards: No specific awards listed in the provided materials, though her collaborative research contributions are notable in high-impact journals.